Widow Donates $1M to Hospital for Permanent PET Scanner in Late Husband's Honor

Why It Matters

The donation fast‑tracks a critical imaging upgrade, expanding access to advanced cancer diagnostics and reducing treatment delays in a growing market. It also illustrates how private philanthropy can bridge funding gaps in regional health systems.

Key Takeaways

• Bloodgood donates $1M for permanent PET/CT scanner at Hancock Health
• Current mobile PET scanner visits only once weekly, causing delays
• PET/CT demand rose 60% in three years, straining capacity
• Foundation's $3M campaign accelerated by Bloodgood's gift, shortening timeline

Pulse Analysis

Positron emission tomography combined with computed tomography (PET/CT) is a cornerstone of modern oncology, enabling physicians to stage tumors, monitor therapy response, and detect recurrence with high precision. Many midsize hospitals, like Hancock Health in Greenfield, Indiana, still depend on mobile PET units that rotate among facilities, limiting scan availability and extending patient wait times. As the prevalence of cancer rises and personalized treatment regimens become more common, the pressure on imaging services has intensified, reflected in a 60% increase in regional PET/CT demand over the last three years.

The $1 million donation from Carole Bloodgood dramatically reshapes Hancock Health’s imaging roadmap. By injecting capital into the $3 million Future Focus campaign, the gift reduces the funding gap and compresses the projected timeline for installing a dedicated PET/CT scanner. Hospital executives anticipate that on‑site capability will cut appointment backlogs, lower transportation costs for patients, and improve coordination with the oncology department, which expects faster diagnostic turnaround to inform treatment decisions. In turn, reduced wait times can translate into better clinical outcomes and higher patient satisfaction scores, vital metrics for community hospitals competing for referrals.

Beyond the immediate clinical benefits, Bloodgood’s contribution underscores a broader trend of private philanthropy stepping in to fund high‑cost medical technology. As reimbursement models evolve and public funding remains constrained, hospitals increasingly rely on donors to bridge capital shortfalls. Such gifts not only accelerate infrastructure projects but also signal community commitment to advanced care, enhancing the institution’s reputation and potentially attracting further investment. For regional health systems, strategic donor partnerships may become essential to sustain cutting‑edge services and remain competitive in the evolving healthcare landscape.